S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
S&P 500   3,128.21 (-3.03%)
DOW   27,081.36 (-3.15%)
QQQ   215.37 (-2.72%)
AAPL   288.08 (-3.39%)
FB   196.77 (-1.97%)
MSFT   168.07 (-1.65%)
GOOGL   1,386.32 (-2.36%)
AMZN   1,972.74 (-1.82%)
CGC   19.62 (-3.35%)
NVDA   262.05 (-4.11%)
BABA   205.61 (-0.27%)
MU   52.10 (-5.29%)
GE   11.32 (-4.55%)
TSLA   799.91 (-4.06%)
AMD   47.57 (-3.16%)
T   37.35 (-1.84%)
ACB   1.51 (-2.58%)
F   7.23 (-4.49%)
NFLX   360.09 (-2.34%)
PRI   121.42 (-4.37%)
BAC   31.08 (-5.04%)
DIS   128.19 (-3.62%)
GILD   70.10 (-3.84%)
Log in

NASDAQ:NXTM - NxStage Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$30.00
0.00 (0.00 %)
(As of 02/21/2019)
Today's Range
$29.98
Now: $30.00
$30.00
50-Day Range
$30.00
MA: $30.00
$30.00
52-Week Range
$23.17
Now: $30.00
$30.00
Volume2.61 million shs
Average Volume1.51 million shs
Market Capitalization$2.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.25
NxStage Medical, Inc, a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:NXTM
CUSIP67072V10
Phone978-687-4700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$393.94 million
Cash Flow$0.29 per share
Book Value$3.22 per share

Profitability

Net Income$-14,470,000.00

Miscellaneous

EmployeesN/A
Market Cap$2.00 billion
Next Earnings DateN/A
OptionableOptionable

Receive NXTM News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTM and its competitors with MarketBeat's FREE daily newsletter.


NxStage Medical (NASDAQ:NXTM) Frequently Asked Questions

What is NxStage Medical's stock symbol?

NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM."

How were NxStage Medical's earnings last quarter?

NxStage Medical, Inc. (NASDAQ:NXTM) posted its quarterly earnings data on Monday, August, 7th. The medical device company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.00. The medical device company earned $92.20 million during the quarter, compared to analysts' expectations of $96.47 million. NxStage Medical had a negative net margin of 1.29% and a negative return on equity of 2.50%. The business's quarterly revenue was up .0% on a year-over-year basis. During the same quarter last year, the business earned ($0.03) earnings per share. View NxStage Medical's Earnings History.

Has NxStage Medical been receiving favorable news coverage?

Press coverage about NXTM stock has trended very negative recently, InfoTrie reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NxStage Medical earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for NxStage Medical.

Who are some of NxStage Medical's key competitors?

What other stocks do shareholders of NxStage Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NxStage Medical investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and ALJ Regional (ALJJ).

Who are NxStage Medical's key executives?

NxStage Medical's management team includes the folowing people:
  • Mr. Jeffrey H. Burbank, Founder, CEO & Director (Age 56)
  • Mr. Joseph E. Turk Jr., Pres (Age 51)
  • Mr. Matthew W. Towse, Sr. VP, CFO & Treasurer (Age 56)
  • Ms. Winifred L. Swan, Sr. VP, Gen. Counsel & Sec. (Age 55)
  • Dr. Allan J. Collins, Head of Scientific Advisory Board & Chief Medical Officer

What is NxStage Medical's stock price today?

One share of NXTM stock can currently be purchased for approximately $30.00.

How big of a company is NxStage Medical?

NxStage Medical has a market capitalization of $2.00 billion and generates $393.94 million in revenue each year. The medical device company earns $-14,470,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. View Additional Information About NxStage Medical.

What is NxStage Medical's official website?

The official website for NxStage Medical is http://www.nxstage.com/.

How can I contact NxStage Medical?

NxStage Medical's mailing address is 350 MERRIMACK STREET, LAWRENCE MA, 01843. The medical device company can be reached via phone at 978-687-4700 or via email at [email protected]


MarketBeat Community Rating for NxStage Medical (NASDAQ NXTM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  376 (Vote Outperform)
Underperform Votes:  338 (Vote Underperform)
Total Votes:  714
MarketBeat's community ratings are surveys of what our community members think about NxStage Medical and other stocks. Vote "Outperform" if you believe NXTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel